Skip to main content
Top
Published in: Diagnostic Pathology 1/2014

Open Access 01-12-2014 | Research

Podocin and Beta Dystroglycan expression to study Podocyte-Podocyte and basement membrane matrix connections in adult protienuric states

Authors: Praveen B Shankar, Ritambhra Nada, Kusum Joshi, Ashwani Kumar, Charan Singh Rayat, Vinay Sakhuja

Published in: Diagnostic Pathology | Issue 1/2014

Login to get access

Abstract

Background

Podocytes can be the primary site of injury or secondarily involved in various protienuric states. Cross talk between adjacent foot processes and with basement membrane is important for slit diaphragm function. Does expression of podocyte associated proteins in kidney biopsies alter with site/type of primary injury? Genetic mutations of podocin result in steroid resistant FSGS. Can protein expression of podocin predict resistant cases to initiate further genetic evaluation?

Methods

Adult patients (n-88) with protienuria- minimal change disease(MCD)-22, focal segmental glomerulosclerosis(FSGS)-21,membranous glomerulonephritis(MGN)-25 and IgA nephropathy(IgAN)-20 were selected for immunohistochemistry with podocin and beta dystroglycan . Results were graded (0 - 3+scale )and compared with control biopsies and internal control. Treatment and follow up (6 months -2 ½ years) of FSGS and MCD cases were collected.

Results

There was intense to moderate staining of the podocytes with podocin and β dystroglycan in the glomeruli in all cases (MCD, FSGS, IgAN and MGN) except for weak staining with β dystroglycan in 3 cases of MCD. There was loss of immunostains in areas of segmental/global sclerosis. There was no significant difference in the staining pattern between the groups. In primary podocytopathies, staining pattern did not differ between steroid resistant, sensitive or dependent cases.

Conclusions

Immunohistochemical expression of podocin and β dystroglycan does not differ in nephropathies which have different site of injury depending on absence (MCD and FSGS) or presence of immune deposits and their localization (MGN and IgAN). Podocin and β dystroglycan staining did not differentiate steroid sensitive and resistant cases, hence, does not give clue to initiate genetic studies. However, analysis of bigger cohort may be required.

Summary

Podocin and β dystroglycan immunohistochemistry was done to analyze podocyte - podocyte and podocyte -basement membrane matrix connections in adult protienuric states. Primary podocytopathies i.e. MCD and FSGS and secondary podocytopathy due to immune complex deposition i.e. MGN (subepithelial) and IgAN (mesangial) were analyzed. There was no difference in staining patterns between primary and secondary podocytopathies or between steroid sensitive, resistant and dependent cases of FSGS and MCD.

Virtual slides

Appendix
Available only for authorised users
Literature
1.
go back to reference Pollak MR: Inherited Podocytopathies: FSGS and Nephrotic Syndrome from a Genetic Viewpoint. J Am Soc Nephrol. 2002, 13: 3016-3023. 10.1097/01.ASN.0000039569.34360.5E.PubMedCrossRef Pollak MR: Inherited Podocytopathies: FSGS and Nephrotic Syndrome from a Genetic Viewpoint. J Am Soc Nephrol. 2002, 13: 3016-3023. 10.1097/01.ASN.0000039569.34360.5E.PubMedCrossRef
2.
go back to reference Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D'Agati V, Appel G: Adult Minimal-Change Disease: Clinical Characteristics, Treatment, and Outcomes. Clin J Am Soc Nephrol. 2007, 2: 445-453. 10.2215/CJN.03531006.PubMedCrossRef Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D'Agati V, Appel G: Adult Minimal-Change Disease: Clinical Characteristics, Treatment, and Outcomes. Clin J Am Soc Nephrol. 2007, 2: 445-453. 10.2215/CJN.03531006.PubMedCrossRef
3.
go back to reference Skoberne A, Konieczny A, Schiffer M: Glomerular epithelial cells in the urine: what has to be done to make them worthwhile?. Am J Physiol Renal Physiol. 2008, 296: 230-241. 10.1152/ajprenal.90507.2008.CrossRef Skoberne A, Konieczny A, Schiffer M: Glomerular epithelial cells in the urine: what has to be done to make them worthwhile?. Am J Physiol Renal Physiol. 2008, 296: 230-241. 10.1152/ajprenal.90507.2008.CrossRef
4.
go back to reference Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H: The urinary pododcyte as a marker for the differential diagnosis of idiopathic focal segmental glomerulosclerosis and minimal change nephrotic syndrome. Am J Nephrol. 2000, 20: 175-179. 10.1159/000013580.PubMedCrossRef Nakamura T, Ushiyama C, Suzuki S, Hara M, Shimada N, Ebihara I, Koide H: The urinary pododcyte as a marker for the differential diagnosis of idiopathic focal segmental glomerulosclerosis and minimal change nephrotic syndrome. Am J Nephrol. 2000, 20: 175-179. 10.1159/000013580.PubMedCrossRef
5.
go back to reference Regele Hm FE, Langer B, Poczewki H, Kraxberger I, Bittner Re, Kerjaschki D: Glomerular Expression of Dystroglycans Is Reduced in Minimal Change Nephrosis But Not in Focal Segmental Glomerulosclerosis. J Am Soc Nephrol. 2000, 11: 403-412.PubMed Regele Hm FE, Langer B, Poczewki H, Kraxberger I, Bittner Re, Kerjaschki D: Glomerular Expression of Dystroglycans Is Reduced in Minimal Change Nephrosis But Not in Focal Segmental Glomerulosclerosis. J Am Soc Nephrol. 2000, 11: 403-412.PubMed
6.
go back to reference Vogtländer NP, Van der Vlag J, Bakker MA, Dijkman HB, Wevers RA, Campbell KP, Wetzels JF, Berden JH: Expression of sialidase and dystroglycan in human glomerular diseases. Nephrol Dial Transplant. 2010, 25: 478-484. 10.1093/ndt/gfp465.PubMedCrossRef Vogtländer NP, Van der Vlag J, Bakker MA, Dijkman HB, Wevers RA, Campbell KP, Wetzels JF, Berden JH: Expression of sialidase and dystroglycan in human glomerular diseases. Nephrol Dial Transplant. 2010, 25: 478-484. 10.1093/ndt/gfp465.PubMedCrossRef
7.
go back to reference Giannico G, Yang H, Neilson EG, Fogo AB: Dystroglycan in the Diagnosis of FSGS. Cin J Am Soc Nephrol. 2009, 4: 1747-1753. 10.2215/CJN.01510209.CrossRef Giannico G, Yang H, Neilson EG, Fogo AB: Dystroglycan in the Diagnosis of FSGS. Cin J Am Soc Nephrol. 2009, 4: 1747-1753. 10.2215/CJN.01510209.CrossRef
8.
go back to reference Schmid H, Henger A, Cohen CD, Frach K, Gröne H-J, Schlöndorff D, Kretzler M: Gene Expression Profiles of Podocyte-Associated Molecules as Diagnostic Markers in Acquired Proteinuric Diseases. J Am Soc Nephrol. 2003, 14: 2958-2966. 10.1097/01.ASN.0000090745.85482.06.PubMedCrossRef Schmid H, Henger A, Cohen CD, Frach K, Gröne H-J, Schlöndorff D, Kretzler M: Gene Expression Profiles of Podocyte-Associated Molecules as Diagnostic Markers in Acquired Proteinuric Diseases. J Am Soc Nephrol. 2003, 14: 2958-2966. 10.1097/01.ASN.0000090745.85482.06.PubMedCrossRef
9.
go back to reference Koop K, Eikmans M, Baelde HJ, Kawachi H, de Heer E, Paul LC, Bruijn JA: Expression of Podocyte-Associated Molecules in Acquired Human Kidney Diseases. J Am Soc Nephrol. 2003, 14: 2063-2071. 10.1097/01.ASN.0000078803.53165.C9.PubMedCrossRef Koop K, Eikmans M, Baelde HJ, Kawachi H, de Heer E, Paul LC, Bruijn JA: Expression of Podocyte-Associated Molecules in Acquired Human Kidney Diseases. J Am Soc Nephrol. 2003, 14: 2063-2071. 10.1097/01.ASN.0000078803.53165.C9.PubMedCrossRef
10.
go back to reference Horinouchi I, Nakazato H, Kawano T, Iyama K-i, Furuse A, Arizono K, Machida J, Sakamoto T, Endo F, Hattori S: In situ evaluation of podocin in normal and glomerular diseases. Kidney Int. 2003, 64: 2092-2099. 10.1046/j.1523-1755.2003.00303.x.PubMedCrossRef Horinouchi I, Nakazato H, Kawano T, Iyama K-i, Furuse A, Arizono K, Machida J, Sakamoto T, Endo F, Hattori S: In situ evaluation of podocin in normal and glomerular diseases. Kidney Int. 2003, 64: 2092-2099. 10.1046/j.1523-1755.2003.00303.x.PubMedCrossRef
11.
go back to reference Mao J, Zhang Y, Du L, Dai Y, Yang C, Liang L: Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy. Pediatr Nephrol. 2006, 16: 1666-1675.CrossRef Mao J, Zhang Y, Du L, Dai Y, Yang C, Liang L: Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy. Pediatr Nephrol. 2006, 16: 1666-1675.CrossRef
12.
go back to reference Guan N, Ding J, Zhang J, Yang J: Expression of nephrin, podocin, alpha-actinin, and WT1 in children with nephrotic syndrome. Pediatr Nephrol. 2003, 18: 1122-1127. 10.1007/s00467-003-1240-z.PubMedCrossRef Guan N, Ding J, Zhang J, Yang J: Expression of nephrin, podocin, alpha-actinin, and WT1 in children with nephrotic syndrome. Pediatr Nephrol. 2003, 18: 1122-1127. 10.1007/s00467-003-1240-z.PubMedCrossRef
13.
go back to reference Machuca E, Benoit G, Nevo F, Tête M-J, Gribouval O, Pawtowski A, Brandström P, Loirat C, Niaudet P, Gubler M-C: Genotype-Phenotype Correlations in Non-Finnish Congenital Nephrotic Syndrome. J Am Soc Nephrol. 2010, 21: 1209-1217. 10.1681/ASN.2009121309.PubMedPubMedCentralCrossRef Machuca E, Benoit G, Nevo F, Tête M-J, Gribouval O, Pawtowski A, Brandström P, Loirat C, Niaudet P, Gubler M-C: Genotype-Phenotype Correlations in Non-Finnish Congenital Nephrotic Syndrome. J Am Soc Nephrol. 2010, 21: 1209-1217. 10.1681/ASN.2009121309.PubMedPubMedCentralCrossRef
14.
go back to reference Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler M-C, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet. 2000, 24: 349-354. 10.1038/74166.PubMedCrossRef Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler M-C, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet. 2000, 24: 349-354. 10.1038/74166.PubMedCrossRef
15.
go back to reference Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf E-M, Mucha B: Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome. J Am Soc Nephrol. 2004, 15: 722-732. 10.1097/01.ASN.0000113552.59155.72.PubMedCrossRef Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf E-M, Mucha B: Patients with Mutations in NPHS2 (Podocin) Do Not Respond to Standard Steroid Treatment of Nephrotic Syndrome. J Am Soc Nephrol. 2004, 15: 722-732. 10.1097/01.ASN.0000113552.59155.72.PubMedCrossRef
16.
go back to reference Weber S, Gribouval O, Esquivel EL, Moriniere V, Tete M-J, Legendre C, Niaudet P, Antignac C: NPSH2 mutation analysis show genetic heterogeneity of steroid resistant nephrotic syndrome and low post transplant recurrence. Kidney Int. 2004, 66: 571-579. 10.1111/j.1523-1755.2004.00776.x.PubMedCrossRef Weber S, Gribouval O, Esquivel EL, Moriniere V, Tete M-J, Legendre C, Niaudet P, Antignac C: NPSH2 mutation analysis show genetic heterogeneity of steroid resistant nephrotic syndrome and low post transplant recurrence. Kidney Int. 2004, 66: 571-579. 10.1111/j.1523-1755.2004.00776.x.PubMedCrossRef
17.
go back to reference He N, Zahirieh A, Mei Y, Lee B, Senthilnathan S, Wong B, Mucha B, Hildebrandt F, Cole DE, Cattran D: Recessive NPHS2 (Podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2007, 2: 31-37.PubMedCrossRef He N, Zahirieh A, Mei Y, Lee B, Senthilnathan S, Wong B, Mucha B, Hildebrandt F, Cole DE, Cattran D: Recessive NPHS2 (Podocin) mutations are rare in adult-onset idiopathic focal segmental glomerulosclerosis. Clin J Am Soc Nephrol. 2007, 2: 31-37.PubMedCrossRef
18.
go back to reference Caridi G, Bertelli R, Scolari F, Sanna- Cherchi S, Di Duca M, Ghiggeri GM: Podocin mutations in sporadic focal segmental glomerulosclerosis occurring in adulthood. Kidney Int. 2003, 64: 365-PubMedCrossRef Caridi G, Bertelli R, Scolari F, Sanna- Cherchi S, Di Duca M, Ghiggeri GM: Podocin mutations in sporadic focal segmental glomerulosclerosis occurring in adulthood. Kidney Int. 2003, 64: 365-PubMedCrossRef
19.
go back to reference Tsukaguchi H, Sudhakar A, Le TC, Nguyen T, Yao J, Schwimmer JA, Schachter AD, Poch E, Abreu PF, Appel GB: NPHS2 mutations in late onset focal segmental glomerulosclerosis; R229Q is a common disease associated allele. J Clin Invest. 2002, 110: 1659-1666. 10.1172/JCI0216242.PubMedPubMedCentralCrossRef Tsukaguchi H, Sudhakar A, Le TC, Nguyen T, Yao J, Schwimmer JA, Schachter AD, Poch E, Abreu PF, Appel GB: NPHS2 mutations in late onset focal segmental glomerulosclerosis; R229Q is a common disease associated allele. J Clin Invest. 2002, 110: 1659-1666. 10.1172/JCI0216242.PubMedPubMedCentralCrossRef
20.
go back to reference Huber TB, Reinhardt C, Simons M, Petraschka D: Direct binding of cholesterol and targeting to nephrin to lipid rafts are disrupted in disease causing podocin mutation. J Am Soc Nephrol. 2004, 15: 33A-10.1097/01.ASN.0000102476.50041.44.CrossRef Huber TB, Reinhardt C, Simons M, Petraschka D: Direct binding of cholesterol and targeting to nephrin to lipid rafts are disrupted in disease causing podocin mutation. J Am Soc Nephrol. 2004, 15: 33A-10.1097/01.ASN.0000102476.50041.44.CrossRef
Metadata
Title
Podocin and Beta Dystroglycan expression to study Podocyte-Podocyte and basement membrane matrix connections in adult protienuric states
Authors
Praveen B Shankar
Ritambhra Nada
Kusum Joshi
Ashwani Kumar
Charan Singh Rayat
Vinay Sakhuja
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Diagnostic Pathology / Issue 1/2014
Electronic ISSN: 1746-1596
DOI
https://doi.org/10.1186/1746-1596-9-40

Other articles of this Issue 1/2014

Diagnostic Pathology 1/2014 Go to the issue